Abstract
Compound 20 (CVT-3146 - a 2-[(N-1-(4-N-methylcarboxamidopyrazolyl)] adenosine derivative) and compound 31 (CVT-3033 - a 2-[(4-(1-N-pentyl-pyrazolyl)] adenosine derivative), were found to be short acting functionally selective coronary vasodilators (CV t0.5 = 5.2 ± 0.2 and 3.4 ± 0.5 min, respectively - rat isolated heart 50% reversal time) with good potency (EC50s = 6.4 ± 1.2 nM and 67.9 ± 16.7 nM, respectively), but they possess low affinity for the ADO A2A receptor (Ki = 1122 ± 323 nM and 2138 ± 952 nM, respectively; pig striatum).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
